Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop.
Schuind AE, Rees H, Schiller J, Mugo N, Dull P, Barnabas R, Clifford GM, Liu G, Madhi SA, Morse RB, Moscicki AB, Palefsky JM, Plotkin S, Sierra MS, Slifka MK, Vorsters A, Kreimer AR, Didierlaurent AM. Schuind AE, et al. Among authors: dull p. Prev Med Rep. 2023 Jul 19;35:102331. doi: 10.1016/j.pmedr.2023.102331. eCollection 2023 Oct. Prev Med Rep. 2023. PMID: 37576844 Free PMC article. Review.
Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results.
Barnabas RV, Brown ER, Onono MA, Bukusi EA, Njoroge B, Winer RL, Galloway DA, Pinder LF, Donnell D, N Wakhungu I, Biwott C, Kimanthi S, Heller KB, Kanjilal DG, Pacella D, Morrison S, A Rechkina E, L Cherne S, Schaafsma TT, McClelland RS, Celum C, Baeten JM, Mugo NR; KEN SHE Study Team. Barnabas RV, et al. Nat Med. 2023 Dec;29(12):3224-3232. doi: 10.1038/s41591-023-02658-0. Epub 2023 Dec 4. Nat Med. 2023. PMID: 38049621 Free PMC article. Clinical Trial.
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021.
Ford A, Hwang A, Mo AX, Baqar S, Touchette N, Deal C, King D, Earle K, Giersing B, Dull P, Hall BF. Ford A, et al. Among authors: dull p. Vaccine. 2023 Mar 10;41(11):1799-1807. doi: 10.1016/j.vaccine.2023.02.028. Epub 2023 Feb 18. Vaccine. 2023. PMID: 36803897 Free PMC article. Review.
Single-dose human papillomavirus vaccination: an update.
Kreimer AR, Watson-Jones D, Kim JJ, Dull P. Kreimer AR, et al. Among authors: dull p. J Natl Cancer Inst Monogr. 2024 Nov 1;2024(67):313-316. doi: 10.1093/jncimonographs/lgae030. J Natl Cancer Inst Monogr. 2024. PMID: 39529520
Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer.
Dull PM, Achilles SL, Ahmed R, Barnabas RV, Campos NG, Chirgwin K, Cohen JA, de Sanjosé S, Doorbar J, Einstein MH, Emerson CI, Gottlieb SL, Hildesheim A, Qiao Y, Ruff P, Sampson JN, Sasieni P, Schiffman M, Shin H, Stanley MA, Trimble CL, Wentzensen N, Riemer AB, Schiller JT, Kreimer AR. Dull PM, et al. Vaccine. 2024 Nov 14;42(25):126100. doi: 10.1016/j.vaccine.2024.07.001. Epub 2024 Jul 14. Vaccine. 2024. PMID: 39004526 Free PMC article.
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022.
Prudden HJ, Achilles SL, Schocken C, Broutet N, Canfell K, Akaba H, Basu P, Bhatla N, Chirenje ZM, Delany-Moretlwe S, Denny L, Gamage DG, Herrero R, Hutubessy R, Villa LL, Murillo R, Schiller JT, Stanley M, Temmerman M, Zhao F, Ogilvie G, Kaslow DC, Dull P, Gottlieb SL; Therapeutic HPV Vaccine PPC Expert Consultation Group*. Prudden HJ, et al. Among authors: dull p. Vaccine. 2022 Sep 29;40(41):5843-5855. doi: 10.1016/j.vaccine.2022.08.020. Epub 2022 Aug 22. Vaccine. 2022. PMID: 36008233
Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition Is Associated With Individual Exposure but Not Community-Level Transmission.
Friedman-Klabanoff DJ, Fitzpatrick MC, Deming ME, Agrawal V, Sitar S, Schaafsma T, Brown E, Neuzil KM, Barnabas RV, Laufer MK; Hydroxychloroquine COVID-19 Postexposure Prophylaxis Study Team. Friedman-Klabanoff DJ, et al. J Infect Dis. 2022 Aug 24;226(2):225-235. doi: 10.1093/infdis/jiac029. J Infect Dis. 2022. PMID: 35134185 Free PMC article. Clinical Trial.
Towards a population-based threshold of protection for COVID-19 vaccines.
Goldblatt D, Fiore-Gartland A, Johnson M, Hunt A, Bengt C, Zavadska D, Snipe HD, Brown JS, Workman L, Zar HJ, Montefiori D, Shen X, Dull P, Plotkin S, Siber G, Ambrosino D. Goldblatt D, et al. Among authors: dull p. Vaccine. 2022 Jan 21;40(2):306-315. doi: 10.1016/j.vaccine.2021.12.006. Epub 2021 Dec 15. Vaccine. 2022. PMID: 34933765 Free PMC article.
Evidence for antibody as a protective correlate for COVID-19 vaccines.
Earle KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, Gilbert PB, Siber GR, Dull P, Plotkin SA. Earle KA, et al. Among authors: dull p. Vaccine. 2021 Jul 22;39(32):4423-4428. doi: 10.1016/j.vaccine.2021.05.063. Epub 2021 May 24. Vaccine. 2021. PMID: 34210573 Free PMC article.
99 results